     

I personally mformed this that a specimen(s) would be collected to be used for research
purposes. . I reVIewed the RESEARCH SUBJECT INFORMATION AND CONSENT
FORM w1th the patlent and answered any questions the patient had. The patient then signed the
consent form as a free and voluntary act. A copy of thi ' tained at
our institution.

 
    
   
  

 

[Clinical Informatioﬂ

 

 

 

1 , FgPRESENT ILLNESS:
Chief Complaints WMM PM?“ 7 W9/d-Mal Wad m,

{Lad—Q
Symptoms: W 04‘ O/M” {/99 g .

Clinical Findings:

 

 

 

Performance Scale (Karnofsky Score):
:1 100 Asymptomatic I: 80-90 Symptomatic but Fully Ambulatory 5160-70 Symptomatic, in bed less than 50% of day

C] 40-50 Symptomatic, in bed more than 50% of day, but not bed ridden El 20-30 Bed Ridden

 

 

 

Route

 

. ICAL HISTOR --
Disease Disorder Date Treatment Status

Environmental Hazards:

, Smoki » H
Current Status ' Packs Duration
El YES

Alcohol Consum
Current Status f TYPE Drinks da Duration
1: YES

Use
Current Status ‘ Duration
El YES 0

Relative

Result
D N D Positive:
H B ' El Positive: [3 N D Positive:
H C N C! Positive: E] N 1:] Positive:
AFP I] 13 Positive: III N ' D Positive:

Other' El Negative CI Positive: El Negative '3 Positive:

B/T Cell Markers:

 

  
 
  

 

Results

 

Ultrasound
X-Ra

CT
Endosco
MRI
Bio

 
   
     
 
  

 
 
   

Clinical

Location of Involved L Nodes Location of Distant Metastasis

Clinical
T N M Stage:

 

 

reatment Information]

 

Procedure

ma Tumor
Detailed Location

‘ 9

Extension of Tu

L Nodes
Location of L Nodes # of L Nodes

Palpable, Non-Dissected Lymph Nodes
Dissected Lymph Nodes

Distant Metastasis
Detailed Location

Su ical S
N M

reatment Route

 

  

Pathology Form

 

 

Specimen Information]

 

Frozen Parafﬁn Block Blood/Seru m/Plasma Slide
Diseased Normal Diseased Normal Diseased Normal Diseased Normal

Z 2. a.
Time to LN2 Time to Formalin Time to LN2

Prima Tumor
Size Extension of Tumor Distance to NAT

X cm “ cm

Nodes
Location # Exami # Metastasized

Distant Metastasis
Detailed Location

Patho icalS
pT; N0 M0

 

 

LMicroscopic Description]

 

Cell Distribution Structural Pattern
Diffuse
Mosaic Storiform
Necrosis Fibrosis
L Infiltration Pal
Vascular Invasion C
Clusterized

Alveolar Formation
Indian File Psammoma Calcification

mous + - Adenomatous + - Sarcomatous + - L
Cell Glandular cell Round Cell Cell
Cell Cell Stratification Fibroblast Small Cell
Keratin Secretion Osteoblast RS RS Like
Desmosome Vacuole Inflam. Cell
Pearl Gland formation Plasma Cell
Cellular Differentiation: Well Moderate Poor

Nuclear II

Aniso Nucleosis

Nucleolar Prominent
Multinucleated Giant Cell
Mitotic
Nuclear Grade:

Marker Result
ER 've 1:1 Positive

pR 've :1 Positive

Her— neu El Positive
B-Cell Marker 've 1: Positive

T-Cell Marker ve :1 Positive
Other: ve :1 Positive

Other: , ' :1 Positive

 

 

lFinal Patholog Reporlj

Histological Diagnosis: \f/y/OZ/S ao/GﬂOaaKCj/DOW3 ‘ﬁ’f 7/Q (dag/Iigb/CQW
i M? Jamie/f; ﬂail/ﬂigéﬂl/l 752/192" 7 Grade: 4:

Comments:

 

 

l. Histological pattern:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

CELL DlS'l' RIB
Diffuse UTl ON + - STRUCTURAL PATTERN
Mosaic 5"“.‘L‘m'
Necrosis a W SSMﬁim
Lymphocytic Inﬁltration 6/ Edi-m”?
Vascular invasion a Ca ”Fain .
Clusterized ysnc Degeneration
Alveolar Formation 1% EdwCMnje
l “d. .
'3" me a] Psammoma/Calciﬁcation
2. Cellular features: "
unmous + - Adenomatous + - Sarcomatous + L II t

Squammd Cell Glandular cell 1/ Round‘Cell 11.2363? m
3 Indie Cell Cell Stratification Fibroblast Small Cell
Keraltn Secretion 0/ Osteoblast RS Cell/RS Like
Desmosome lntiacyt. Vacuole 5X Lipoblast lnﬂam. Cell
Pearl Gland formation ,1 Myoblast Plasma Cell
Otherwise Speciﬁed: ' ' \ ~— :

pf :77, pet, a? 9 a2 a? 2 .52 Q

2. Cellular Dfﬁ'erenu’arion:
Well Moderately Poor
oer

 

 

 

 

3. Nuclear
Aniso

Prominent

Mitotic

Nuclear Grade

 

 

Histological Diagnosis: Q ﬂ 4 4 z 10 (2’1 C/Wl .

 

 

 

 

 

